Ikarian Capital, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Ikarian Capital, LLC
- $573 Million
- Q3 2024
A detailed history of Ikarian Capital, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Ikarian Capital, LLC holds 5,095 shares of RVPH stock, worth $6,470. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,095Holding current value
$6,470% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RVPH
# of Institutions
40Shares Held
9.97MCall Options Held
133KPut Options Held
43.9K-
Armistice Capital, LLC New York, NY3.19MShares$4.05 Million0.08% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.83MShares$2.33 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.52MShares$1.93 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$1.3 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA685KShares$869,7020.01% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $26M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...